85 related articles for article (PubMed ID: 2219928)
1. [Caffeine blood concentration as an indicator of liver damage in patients with cirrhosis--correlation with Child's classification].
Habior A
Wiad Lek; 1990 May 1-15; 43(9-10):412-6. PubMed ID: 2219928
[TBL] [Abstract][Full Text] [Related]
2. The theophylline disposition after caffeine administration in liver cirrhosis: an index of liver function.
Hartleb M; Romańczyk T; Becker A; Mańczyk I; Waluga M; Spalińska M; Zieliński M
Ital J Gastroenterol; 1992; 24(6):332-7. PubMed ID: 1515659
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of the study of caffeine elimination in chronic liver diseases].
Darnót G; Nemesánszky E; Bariska J
Orv Hetil; 1995 Apr; 136(18):927-32. PubMed ID: 7739851
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels.
Sohara N; Takagi H; Kakizaki S; Sato K; Mori M
Liver Int; 2005 Feb; 25(1):28-32. PubMed ID: 15698395
[TBL] [Abstract][Full Text] [Related]
5. Correlation of caffeine elimination and Child's classification in liver cirrhosis.
Holstege A; Staiger M; Haag K; Gerok W
Klin Wochenschr; 1989 Jan; 67(1):6-15. PubMed ID: 2921843
[TBL] [Abstract][Full Text] [Related]
6. Assessment of liver function by the aminopyrine breath test.
Villeneuve JP; Arsène D; Huet PM
Clin Invest Med; 1983; 6(1):5-9. PubMed ID: 6403268
[TBL] [Abstract][Full Text] [Related]
7. Influence of smoking on cotinine and caffeine plasma levels in patients with alcoholic liver cirrhosis.
Langmann P; Bienert A; Zilly M; Väth T; Richter E; Klinker H
Eur J Med Res; 2000 May; 5(5):217-21. PubMed ID: 10806124
[TBL] [Abstract][Full Text] [Related]
8. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
Joeres R; Brachtel D; Gallenkamp H; Hofstetter G; Klinker H; Zilly W; Richter E
Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
[TBL] [Abstract][Full Text] [Related]
9. Elevated plasma resistin concentrations in patients with liver cirrhosis.
Kakizaki S; Sohara N; Yamazaki Y; Horiguchi N; Kanda D; Kabeya K; Katakai K; Sato K; Takagi H; Mori M
J Gastroenterol Hepatol; 2008 Jan; 23(1):73-7. PubMed ID: 18171344
[TBL] [Abstract][Full Text] [Related]
10. [Use of the paraxanthine/caffeine ratio in the saliva of patients with liver cirrhosis].
Perlík F; Pucelíková T; Slanar O
Cas Lek Cesk; 2001 Feb; 140(2):51-3. PubMed ID: 11262908
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and determinants of elevated plasma norepinephrine concentration in compensated cirrhosis.
Rector WG; Robertson AD
Am J Gastroenterol; 1994 Nov; 89(11):2049-53. PubMed ID: 7942734
[TBL] [Abstract][Full Text] [Related]
12. Caffeine clearance study in hepatocellular carcinoma.
Tangkijvanich P; Wittayalertpanya S; Kusonsolboon T; Thong-Ngam D; Mahachai V
J Med Assoc Thai; 1999 Mar; 82(3):297-303. PubMed ID: 10410486
[TBL] [Abstract][Full Text] [Related]
13. [Hepatopulmonary syndrome in liver cirrhosis].
Culafić Dj; Perisić M; Rebić P
Srp Arh Celok Lek; 2000; 128(7-8):271-5. PubMed ID: 11089435
[TBL] [Abstract][Full Text] [Related]
14. Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis.
Flisiak R; Pytel-Krolczuk B; Prokopowicz D
Cytokine; 2000 Jun; 12(6):677-81. PubMed ID: 10843744
[TBL] [Abstract][Full Text] [Related]
15. Serum metabolite/caffeine ratios as a test for liver function.
Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic cholecystectomy and cirrhosis: a case-control study of outcomes.
Fernandes NF; Schwesinger WH; Hilsenbeck SG; Gross GW; Bay MK; Sirinek KR; Schenker S
Liver Transpl; 2000 May; 6(3):340-4. PubMed ID: 10827236
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of the value of serum caffeine and bile acid concentrations as indicators of liver injury].
Habior A; Ostrowski J; Trzeciak L; Wojciechowski K
Pol Arch Med Wewn; 1990 Nov; 84(5):284-91. PubMed ID: 2075120
[TBL] [Abstract][Full Text] [Related]
18. [One point determination of oral caffeine clearance in patients with liver diseases].
Richter E; Brachtel D; Hofstetter G; Joeres R; Klinker H; Junggeburth J; Epping J; Zilly W
Z Gastroenterol; 1988 Dec; 26(12):744-9. PubMed ID: 3149826
[TBL] [Abstract][Full Text] [Related]
19. Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function.
Park GJ; Katelaris PH; Jones DB; Seow F; Le Couteur DG; Ngu MC
Hepatology; 2003 Nov; 38(5):1227-36. PubMed ID: 14578861
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of renal blood flow and endothelin in cirrhotic patients].
Yan Y; Zhang BL
Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):278-80. PubMed ID: 15161502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
